Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Tramadol Use for Noncancer Pain Linked With Increased Hip Fracture Risk

Publish date:: February 14, 2020

Key clinical point: Tramadol, compared with other NSAIDs for chronic noncancer pain, was associated with increased hip fracture risk.

Major finding: Hip fracture incidence with tramadol vs. codeine was 3.7 vs. 2.9 per 1,000 person-years, respectively (HR, 1.28).

Study details: A large population-based cohort study including nearly 294,000 patients.

Disclosures: This study was supported by the National Institutes of Health, the National Natural Science Foundation of China, and the Postdoctoral Science Foundation of Central South University. The authors reported having no conflicts of interest.

Citation:

Wei J et al. J Bone Miner Res. 2019 Feb 5. doi: 10.1002/jbmr.3935

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Pain

Diabetic neuropathic pain linked to brain bioenergic anomalies,

Yoga is a good adjunct to migraine therapy,

Tramadol Use for Noncancer Pain Linked With Increased Hip Fracture Risk,

Migraine Comorbidities Rise With Increased Headache Days,

Medication Overuse Prevalent Among US Migraine Patients,